chronic disease

New regulatory frameworks, shifting incentives, and pragmatic trial designs could finally move patient engagement from rhetoric to reality.

Endometriosis is still largely managed with pain relief, hormones, and surgery, but a new precision peptide therapy seeks to directly target the underlying lesion biology.

The collaboration combines VRG’s AI platform with AOP Health’s expertise in rare diseases and immunology to develop a highly selective therapeutic targeting Kv1.3-mediated immune dysfunction.

This new test offers clinicians a tool to detect endometriosis in patients whose lesions may be missed by standard imaging, helping address years-long delays in diagnosis.

Machine learning helps translate complex DNA fragment patterns into disease-specific signatures, offering a new path for early detection.

Researchers uncover how microbes targeting the colon’s mucus may explain treatment-resistant constipation in Parkinson’s disease and other patients.

Expanded high-value end-to-end solution positions business for rapid growth in multi-billion dollar functional GI market

Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs. 

Epithelial cells partner with tissue-resident memory cells to protect the lung during Streptococcus pneumoniae infection.